NWRD-09

N/A

Report date: 2026/05/22 20:01:29

Base Information

Drug NameNWRD-09
Drug Alias NameNWRD09NWRD-09
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSquamous Intraepithelial Lesions of the CervixAtypical Squamous Cells of the CervixUterine Cervical Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNuowei Biotechnology (Wuxi) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNewish Technology (Beijing) Co LtdNewish Biotech (Wuxi) Co LtdNuowei Biotechnology (Wuxi) Co Ltd
Inactive CompaniesN/A
Active IndicationsSquamous Intraepithelial Lesions of the CervixAtypical Squamous Cells of the CervixUterine Cervical Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A